Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: A potential pitfall

American Journal of Surgical Pathology

Volumn 28, Issue 12, 2004, Pages 1646-1651

  Recine, Monica A ^a   Deavers, Michael T ^a   Middleton, Lavinia P ^a   Silva, Elvio G ^a   Malpica, Anais ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Axillary lymph node; Breast; Metastasis; Ovary; Peritoneum; Serous carcinoma

Indexed keywords

PEROXIDASE; WT1 PROTEIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST METASTASIS; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; INFORMATION PROCESSING; LYMPH NODE METASTASIS; OVARY CARCINOMA; PAPILLOMA; PATIENT SELECTION; PERITONEUM CANCER; PROGNOSIS; SEROUS CARCINOMA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BREAST NEOPLASMS; CYSTADENOCARCINOMA, SEROUS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 9444295960     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200412000-00015     Document Type: Article

References (43)

1. Abrams HL, Spiro R, Goldstein N. Metastases in carcinomas: analysis of 1000 autopsied cases. Cancer. 1950;3:74-85.
2. Al-Hussaini M, Stockman A, Foster H, et al. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinomas. Histopathology. 2004;44:109-115.
3. Bohman LG, Bassett LW, Gold RH, et al. Breast metastasis from extra-mammary malignancies. Radiology. 1982;144:309-312.
4. Bonnefoi H, A'Hern RP, Fisher C, et al. Natural history of stage IV epithelial ovarian cancer. Am J Clin Oncol. 1999;17:767-775.
5. Cormio G, Rossi C, Cazzolla A, et al. Distant metastases in ovarian carcinoma. Int J Gynecol Cancer. 2003;13:125-129.
6. Cormio G, Maneo A, Parma G, et al. Central nervous system metastases in patients with ovarian carcinoma. Ann Oncol. 1995;6:571-574.
7. Cormio G, diVagno G, Melilli GA, et al. Ovarian carcinoma metastatic to the breast. Gynecol Obstet Invest. 2001;52:73-74.
8. Dauplat J, Hacker NF, Nieberg RK, et al. Distant metastases in epithelial ovarian carcinoma. Cancer. 1987;60:1561-1566.
9. Dihn TV, Liebowitz BL, Hanningan EV, et al. Bone metastasis in epithelial ovarian carcinomas. Int J Gynecol Obstet. 1996;52:173-176.
10. Duda RB, August CZ, Schink JC. Ovarian carcinoma metastatic to the breast and axillary node. Surgery. 1991;110:552-556.
11. Dvoretsky PM, Richard KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol. 1988;19:57-63.
12. Euscher ED, Elishaev E, Silva EG, et al. Serous carcinoma of the ovary, fallopian tube or peritoneum with initial presentation as a lymph node metastasis [Abstract]. Mod Pathol. 2003;16:188.
13. Fishman A, Kim HS, Girtanner RE, et al. Solitary breast metastasis as first manifestation of ovarian carcinoid tumor. Gynecol Oncol. 1994;54:222-226.
14. Fondrinier E, Gamelin E, Verriete V. Inflammatory breast metastasis from primary ovarian cancer: case report. Eur J Gynaecol Oncol. 1999;20:16-17.
15. Gemignani ML, Chi DS, Gurin CC, et al. Splenectomy in recurrent epithelial ovarian career. Gynecol Oncol. 1999;72:407-410.
16. Gupta D, Merino M, Farhood A, et al. Metastases of breast simulating ductal carcinoma in situ: report of two cases and review of the literature. Ann Diagn Pathol. 2001;5:15-20.
17. Hajdu SI, Urban JA. Cancers metastatic to the breast. Cancer. 1972;29:1691-1696.
18. Hashi A, Yuminamochi T, Murata SI, et al. Wilms tumor gene immunoreactivity in primary serous carcinoma of the fallopian tube, ovary, endometrium and peritoneum. Int J Gynecol Pathol. 2003;22:374-377.
19. Hardwood TR. Metastatic carcinoma to the breast. JAMA. 1971;218:97.
20. Hennigan CA, Bur M, Donovan JT. Fine-needle aspiration in the diagnosis of metastatic ovarian cancer to the breast. Gynecol Oncol. 1997;64:533-540.
21. Hockstein S, Keh P, Lurain JR, et al. Ovarian carcinoma initially presenting as metastatic axillary lymphadenopathy. Gynecol Oncol. 1997;65:543-547.
22. Ibach JR. Carcinoma of the ovary metastatic to breast. Arch Surg. 1964;88:410-414.
23. Kattan J, Droz JP, Charpenter P, et al. Ovarian dysgerminoma metastatic to the breast: case report. Gynecol Oncol. 1992;46:104-106.
24. Krishnan EU, Phillips AK, Randell A, et al. Bilateral metastatic inflammatory carcinoma in the breast from primary ovarian cancer. Obstet Gynecol. 1980;55(suppl):94-96.
25. Lee BH, Hecht JL, Pinkus JL, et al. WT1, estrogen receptor and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinomas to body fluids. Am J Clin Pathol. 2002;117:745-750.
26. Loredo DS, Powell JL, Reed WP, et al. Ovarian carcinoma metastatic to the breast: case report and review of the literature. Gynecol Oncol. 1990;37:432-436.
27. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004;28:496-504.
28. McIntoch IH, Hooper AA, Millis RR, et al. Metastatic carcinoma within the breast. Clin Oncol. 1976;2:393-401.
29. Monteagudo C, Merino MJ, LaPorte N, et al. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary. Hum Pathol. 1991;22:368-372.
30. Ordoñez NG. Value of TTF-1, E-cadherin, BG8, WT1 and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma. Am J Surg Pathol. 2000;24:598-606.
31. Ozsaran AA, Dikmen Y, Terek MC, et al. Bilateral metastatic carcinoma of the breast from primary ovarian cancer. Arch Gynecol Obstet. 2000;264:166-167.
32. Paulus DD, Libshitz HI. Metastasis to the breast. Radiol Clin North Am. 1982;20:561-568.
33. Petersen BL, Hogdall E, Kryger-Baggesen N. Metastasis to breast from an ovarian carcinoma. Acta Obstet Gynecol Scand. 1999;78:826-827.
34. Pettinato G, Manivel CJ, Panico L, et al. Invasive micropapillary carcinoma of the breast: clinicopathologic study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am J Clin Pathol. 2004;121:857-866.
35. Raptis S, Kanbour AI, Dusenbery D, et al. Fine-needle aspiration cytology of metastatic ovarian carcinomas to the breast. Diagn Cytopathol. 1996;15:1-6.
36. Rose PG, Piver S, Tsukada Y, et al. Metastatic patterns in histologic variants of ovarian cancer: an autopsy study. Cancer. 1989;64:1508-1513.
37. Rosen PP. Rosen's Breast Pathology, 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2001:561-564.
38. Shimizu M, Toki T, Takagi Y, et al. Immunohistochemical detection of the Wilms' tumor gene (WT-1) in epithelial ovarian tumors. Int J Gynecol Pathol. 2000;19:158-163.
39. Sitzenfrey A. Mammakarzinom zwei Jahre nach abdominaler: radikaloperation wegen doppelseitigen carcinoma ovarii. Prag Med Wochenschr. 1907;32:221-235.
40. Silberstein GB, Van Horn K, Strickland P, et al. Altered expression of the WT-1 Wilms tumor suppressor gene in human breast cancer. Proc Natl Acad Sci USA. 1997;94:8132-8137.
41. Toombs BD, Kalisher L. Metastatic disease to the breast: clinical, pathologic, and radiographic features. AJR Am J Roentgenol. 1977;129:673-676.
42. Wick MR, Lillemoe TJ, Copland GT, et al. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol. 1989;20:281-287.
43. Yamasaki H, Saw D, Zdanowitz J, et al. Ovarian carcinoma metastasis to the breast: case report and review of the literature. Am J Surg Pathol. 1993;17:193-197.